Skip to main content
SpringerLink
Log in

Depression in Cancer Patients

  • Chapter
  • First Online:
Supportive Care in Cancer Therapy

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

Oncologists commonly encounter patients with depressive symptoms. It is important for the clinician to recognize and treat these symptoms in cancer patients, since they can occur for both physical and psychological reasons. This chapter describes assessment of depression, differentiating between types and causes of depressive disorders, and treatment interventions. Risk factors for suicide, assessment and management of suicide are also reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bukberg J, Penman D, Holland JC. 1984; Depression in hospitalized cancer patients. Psychosom Med 46:199–212.

    PubMed  CAS  Google Scholar 

  2. Massie MJ. 2004; Prevalence of depression in patients with cancer J of National Cancer Inst Monogr 32:57–71.

    Article  Google Scholar 

  3. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. 1995; Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89–99.

    Article  PubMed  CAS  Google Scholar 

  4. Blazer DG, Kessler KC, McGonagle KA, Swartz MS.. 1994; The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey Am J Psychiatry 151:979–986.

    PubMed  CAS  Google Scholar 

  5. Chochinov HM, Wilson KG, Enns M, Lander S. 1994; Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 151:537–540.

    PubMed  CAS  Google Scholar 

  6. Coups EJ, Winell J, Holland JC. 2005:Depression in the context of cancer. In: Licinio J, Ma-Le Wong, eds. Biology of Depression: From Novel Insights to Therapeutic Strategies, Vol. 1. Wiley, Weinheim, Germany: 365–385.

    Google Scholar 

  7. Roth AJ, Holland JC. 1994; Treatment of depression in cancer patients. Prim Care Cancer 14:23–29.

    Google Scholar 

  8. Cohen-Cole SA, Brown FW, McDanile JS. 1993:Diagnostic assessment of depression in the medically ill. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. Oxford University Press, New York: 53–70.

    Google Scholar 

  9. Spitzer RL, Endicott J, Robins E. 1978; Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782.

    Article  PubMed  CAS  Google Scholar 

  10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.

    Google Scholar 

  11. Medical Letter. Drugs that cause psychiatric symptoms. Med Lett 1993;35:65–70.

    Google Scholar 

  12. Newport DJ, Nemeroff CB. 1998; Assessment and treatment of depression in the cancer patient. J Psychosom Res 45:215–237.

    Article  PubMed  CAS  Google Scholar 

  13. Ebrahimi B, Tucker SL, Li D, et al. 2004; Cytokines in pancreatic carcinoma. Cancer 101:2727–2736.

    Article  PubMed  CAS  Google Scholar 

  14. Lerner DM, Stoudemire A, Rosenstein DL. 2001:Cytokine-induced neuropsychiatric toxicity. In: Holland SM, ed. Cytokine Therapeutics in Infectious Diseases. Lippincott Williams & Wilkins, Philadelphia, PA: 323–332.

    Google Scholar 

  15. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S,. et al. 2001; Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961–966.

    Article  PubMed  CAS  Google Scholar 

  16. Holland JH, Friedlander MM. 2006:Oncology. In: Blumenfield M, Strain JJ, eds. Psychosomatic Medicine. Lippincott Williams & Wilkins, Philadelphia, PA: 121–144.

    Google Scholar 

  17. Plumb MM, Holland JC. 1981; Comparative studies of psychological function in patients with advanced cancer – II. Interviewer-rated current and past psychological symptoms. Psychosom Med 43:243–254.

    PubMed  CAS  Google Scholar 

  18. Spiegel D, Sand S, Koopman C. 1994; Pain and depression in patients with cancer. Cancer 74:2570–2578.

    Article  PubMed  CAS  Google Scholar 

  19. Kathol RG, Mutgi A, Williams J, Clamon G, Noyes RJr.1990; Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 147:1021–1024.

    PubMed  CAS  Google Scholar 

  20. Schroevers MJ, Ranchor AV, Sanderman R. 2003; The role of social support and self-esteem in the presence and course of depressive symptoms: a comparison of cancer patients and individuals from the general population. Soc Sci Med 57:375–385.

    Article  PubMed  Google Scholar 

  21. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. 1993; Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29:85–96.

    Article  PubMed  CAS  Google Scholar 

  22. DeFlorio ML, Massie MJ. 1995; Review of depression in cancer: gender differences. Depression 3:66–80.

    Article  Google Scholar 

  23. Bolund C. 1985; Suicide and cancer. II: Medical and care factors in suicide by cancer patients in Sweden. 1973–1976. J Psychosoc Oncol 3:17–30.

    Article  Google Scholar 

  24. Farberow NL, Ganzler S, Cuter F, Reynolds D. 1971; An eight-year survey of hospital suicides. Suicide Life Threat Behav 1:198–201.

    Google Scholar 

  25. Louhivuori KA, Hakama J. 1979; Risk of suicide among cancer patients. Am J Epidemiol 109:59–65.

    PubMed  CAS  Google Scholar 

  26. Weisman AD. 1976.Coping behavior and suicide in cancer. In: Cullen JW, Fox BH, Ison RN, eds. Cancer: The Behavioral Dimensions. Raven press, New York:

    Google Scholar 

  27. Conwell Y, Caine ED. 1991; Rational suicide and the right to die: reliability and myth. N Engl J Med 325:1100.

    Article  PubMed  CAS  Google Scholar 

  28. Chochinov HM, Wilson KG, Ennis M,. et al. 1995; Desire for death in the terminally ill. Am J Psychiatry 152:1185–1191.

    PubMed  CAS  Google Scholar 

  29. Chochinov HM, Wilson KG, Ennis M, Lander S. 1998; Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 39:336–370.

    Article  Google Scholar 

  30. Rosenfeld B, Krevo S, Breitbart W,. et al. 2000:Suicide, assisted suicide, and euthanasia in the terminally ill. In: Chochinov H, Breitbart W, eds. Handbook of Psychiatry in Palliative Medicine. Oxford University Press, New York, NY: 51–63.

    Google Scholar 

  31. Achte KA, Vanhkouen ML. 1971; Cancer and the psyche. Omega 2:46–56.

    Google Scholar 

  32. Breitbart W. 1993:Suicide risk and pain in cancer and AIDS patients. In: Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain: Research and Practice. Raven press, New York, NY: 49–65.

    Google Scholar 

  33. Kendal WS. Suicide and cancer: a gender-comparative study. Ann Oncol 2006 Oct 19; epub ahead of print .

    Google Scholar 

  34. Schairer C, Brown LM, Chen BE,. et al. 2006; Suicide after breast cancer: an international population-based study of 723 810 women. J Natl Cancer Inst 98:1416–1419.

    Article  PubMed  Google Scholar 

  35. Holland JC, Gooen-Piels J:2003:Psycho-oncology. In: Holland JC, Frei E, eds. Cancer Medicine, 6th ed. B.C. Decker Inc, Hamilton, Ontario: 1039–1053.

    Google Scholar 

  36. Hietanen P, Lonnqvist J. 1991; Cancer and suicide. Ann Oncol 2:19.

    PubMed  CAS  Google Scholar 

  37. Breitbart W, Cohen K. 1998:Delirium. In: Holland JC, ed. Psycho-Oncology. Oxford University Press, New York, NY: 564–575.

    Google Scholar 

  38. Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR. 2006; Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol 24:3852–3857.

    Article  PubMed  Google Scholar 

  39. Dubovsky SL. 1978; Averting suicide in terminally ill patients. Psychosomatics 19:113–115.

    PubMed  CAS  Google Scholar 

  40. Potash M, Breitbart W. 2002; Affective disorders in advanced cancer. Hematol/Oncol Clin North Am 16:671–700.

    Article  Google Scholar 

  41. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 2nd ed. Arlington, VA: American Psychiatric Publishing, Inc., 2000.

    Google Scholar 

  42. The National Comprehensive Cancer Network. Distress Management Clinical Practice Guidelines in Oncology, version 1.2007.

    Google Scholar 

  43. Frazer A, Benmansour S. 2002; Delayed pharmacological effects of antidepressants. Mol Psychiatry 7:(Suppl 1)S23–S28.

    Article  PubMed  CAS  Google Scholar 

  44. Hemaryeck A, Belpaire FM. 2002; Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug–drug interactions: an update. Curr Drug Metab 3:13–37.

    Article  Google Scholar 

  45. Joshi N, Breitbart WS. 2003; Psychopharmacologic management during cancer treatment. Semin Clin Neuropsychiatry 8:241–252.

    PubMed  Google Scholar 

  46. DeVane CL. 1998; Differential pharmacology of newer antidepressants. J Clin Psychiatry 59:(Suppl 20)85–93.

    PubMed  CAS  Google Scholar 

  47. Burke WJ. 2002; Escitalopram. Expert Opin Investig Drugs 11:1477–1486.

    Article  PubMed  CAS  Google Scholar 

  48. Masand PS, Gupta S. 1999; Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry 7:69–84.

    PubMed  CAS  Google Scholar 

  49. Horst WD, Preskorn SH. 1998; Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 51:237–254.

    Article  PubMed  CAS  Google Scholar 

  50. Dugan SE, Fuller MA. 2004; Duloxetine: a dual reuptake inhibitor. Ann Pharmacother 38:2078–2085.

    Article  PubMed  CAS  Google Scholar 

  51. Nutt DJ. 2002; Tolerability and safety aspects of mirtazaoine. Hum Psychopharmacol 17:(Suppl 1)S37–S41.

    Article  PubMed  CAS  Google Scholar 

  52. DeMarchi R, Bansal V, Hung A,. et al. 2005; Review of awakening agents. Can J Neurol Sci 32:4–17.

    PubMed  Google Scholar 

  53. Morrow GR, Shelke AR, Roscoe JA,. et al. 2005; Management of cancer-related fatigue. Cancer Invest 23:229–239.

    Article  PubMed  Google Scholar 

  54. Robertson P , Jr.Hellrigel ET. 2003; Clinical pharmacokinetic profile of Modafinil. Clin Pharmacokinet 42:123–137.

    Article  PubMed  CAS  Google Scholar 

  55. Wisor JP, Eriksson KS. 2005; Dopaminergic–adrenergic interactions in the wake promoting mechanism of Modafinil. Neuroscience 132:1027–1034.

    Article  PubMed  CAS  Google Scholar 

  56. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D. 2001; Supportive-expressive group therapy and distress in patient with metastatic cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501.

    Article  PubMed  CAS  Google Scholar 

  57. Kissane DW, Bloch S, Smith GC. et al. 2003; Cognitive-existential group psychotherapy for women with primary breast cancer: a randomized controlled trial. Psychooncology 12:532–546.

    Article  PubMed  Google Scholar 

  58. Beale MD, Kellner CH, Parsons PJ. 1997; ECT for the treatment of mood disorders in cancer patients. Convuls Ther 13:222–226.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY 10022, USA

    Jimmie C. Holland* & Yesne Alici-Evcimen

Authors
  1. Jimmie C. Holland*
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yesne Alici-Evcimen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA

    David S. Ettinger

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Holland*, J., Alici-Evcimen, Y. (2009). Depression in Cancer Patients. In: Ettinger, D.S. (eds) Supportive Care in Cancer Therapy. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-59745-291-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-291-5_7

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-941-3

  • Online ISBN: 978-1-59745-291-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation